Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Multidrug resistance among gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008.

Kallen AJ, Hidron AI, Patel J, Srinivasan A.

Infect Control Hosp Epidemiol. 2010 May;31(5):528-31. doi: 10.1086/652152.

PMID:
20334552
2.
3.

[Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].

Gür D, Gülay Z, Akan OA, Aktaş Z, Kayacan CB, Cakici O, Eraç B, Gültekin M, Oğünç D, Söyletir G, Unal N, Uysal S.

Mikrobiyol Bul. 2008 Oct;42(4):537-44. Turkish.

PMID:
19149074
4.

Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY.

Landman D, Bratu S, Kochar S, Panwar M, Trehan M, Doymaz M, Quale J.

J Antimicrob Chemother. 2007 Jul;60(1):78-82. Epub 2007 May 9.

PMID:
17490999
5.

Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum.

McGowan JE Jr.

Am J Med. 2006 Jun;119(6 Suppl 1):S29-36; discussion S62-70. Review.

PMID:
16735148
6.

The comparison of susceptibility patterns of Gram-negative invasive and non-invasive pathogens in Estonian hospitals.

Lõivukene K, Kermes K, Sepp E, Adamson V, Mitt P, Jürna M, Mägi H, Kallandi U, Otter K, Naaber P.

Antonie Van Leeuwenhoek. 2006 Apr-May;89(3-4):367-71. Epub 2006 Apr 25.

PMID:
16779633
7.

[Carbapenemases in gram-negative bacteria. Current data and trends of resistance resulting from the work of national reference centres].

Kaase M.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Nov;55(11-12):1401-4. doi: 10.1007/s00103-012-1552-x. German.

PMID:
23114438
8.

In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.

Landman D, Singh M, El-Imad B, Miller E, Win T, Quale J.

Int J Antimicrob Agents. 2014 Jun;43(6):527-32. doi: 10.1016/j.ijantimicag.2014.02.017. Epub 2014 Apr 13.

PMID:
24796217
9.
10.

Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.

Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K.

Int J Antimicrob Agents. 2005 Jan;25(1):11-25. Review.

PMID:
15620821
11.

Clinical and economic impact of common multidrug-resistant gram-negative bacilli.

Giske CG, Monnet DL, Cars O, Carmeli Y; ReAct-Action on Antibiotic Resistance.

Antimicrob Agents Chemother. 2008 Mar;52(3):813-21. Epub 2007 Dec 10. Review. No abstract available.

12.
13.

[Evolution of antimicrobial resistance in Gram negative bacilli from intensive care units in Colombia].

Hernández-Gómez C, Blanco VM, Motoa G, Correa A, Vallejo M, Villegas MV; Grupo de Resistencia Bacteriana Nosocomial en Colombia.

Biomedica. 2014 Apr;34 Suppl 1:91-100. doi: 10.1590/S0120-41572014000500011. Spanish.

14.

Influence of antimicrobial consumption on gram-negative bacteria in inpatients receiving antimicrobial resistance therapy from 2008-2013 at a tertiary hospital in Shanghai, China.

Guo W, He Q, Wang Z, Wei M, Yang Z, Du Y, Wu C, He J.

Am J Infect Control. 2015 Apr 1;43(4):358-64. doi: 10.1016/j.ajic.2014.12.010.

PMID:
25838134
15.

Changes in the incidences of multidrug-resistant and extensively drug-resistant organisms isolated in a military medical center.

Keen EF 3rd, Murray CK, Robinson BJ, Hospenthal DR, Co EM, Aldous WK.

Infect Control Hosp Epidemiol. 2010 Jul;31(7):728-32. doi: 10.1086/653617.

PMID:
20500036
16.

Susceptibility of multiresistant gram-negative bacteria to fosfomycin and performance of different susceptibility testing methods.

Perdigão-Neto LV, Oliveira MS, Rizek CF, Carrilho CM, Costa SF, Levin AS.

Antimicrob Agents Chemother. 2014;58(3):1763-7. doi: 10.1128/AAC.02048-13. Epub 2013 Dec 9.

17.

Etiological factors causing lower respiratory tract infections isolated from hospitalized patients.

Guzek A, Rybicki Z, Korzeniewski K, Mackiewicz K, Saks E, Chciałowski A, Zwolińska E.

Adv Exp Med Biol. 2015;835:37-44. doi: 10.1007/5584_2014_23.

PMID:
25310945
18.

Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?

Falagas ME, Bliziotis IA.

Int J Antimicrob Agents. 2007 Jun;29(6):630-6. Epub 2007 Feb 16. Review.

PMID:
17306965
19.

Drug resistance patterns of bacteria isolated from patients with nosocomial pneumonia at Tehran hospitals during 2009-2011.

Haeili M, Ghodousi A, Nomanpour B, Omrani M, Feizabadi MM.

J Infect Dev Ctries. 2013 Apr 17;7(4):312-7. doi: 10.3855/jidc.2604.

20.

Prevalence of multidrug-resistant bacteria at a tertiary-care teaching hospital in Mexico: special focus on Acinetobacter baumannii.

Garza-González E, Llaca-Díaz JM, Bosques-Padilla FJ, González GM.

Chemotherapy. 2010;56(4):275-9. doi: 10.1159/000319903. Epub 2010 Aug 9.

PMID:
20693798

Supplemental Content

Support Center